electroCore to present at European headache meeting on non-invasive vagus nerve stimulation therapy for cluster headache
18 September 2014
This weekend, at the European Headache and Migraine Trust International Congress in Copenhagen (EHMTIC), electroCore will be presenting full data on their PREVA study, a randomized, multi-centre trial across several European countries.
The trial showed that preventative use of non-invasive vagus nerve stimulation (nVNS) can substantially reduce the frequency of cluster headache attacks (ie by 43.4%) versus the control group (the current standard of care, which experienced only a 12% reduction).
Three poster presentations will provide full details of the PREVA trial and include:
On Saturday evening electroCore is hosting a satellite symposium with three eminent headache specialists:
New Jersey based electroCore has developed non-invasive Vagus Nerve Stimulation (nVNS) therapies, which are self-administered by patients for the treatment of multiple conditions in neurology, psychiatry, respiratory and other fields.